Welcome to LookChem.com Sign In|Join Free

CAS

  • or

23580-89-4

Post Buying Request

23580-89-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23580-89-4 Usage

Description

METHYL-(3-PHENYL-PROPYL)-AMINE, also known as N-Methyl-3-phenylpropylamine, is a chemical compound that is identified as an impurity in the pharmaceutical drug Fluoxetine. It is characterized by its molecular structure, which consists of a methyl group attached to a 3-phenylpropylamine backbone. METHYL-(3-PHENYL-PROPYL)-AMINE is relevant in the context of pharmaceutical manufacturing and quality control.
Source:
METHYL-(3-PHENYL-PROPYL)-AMINE is typically found as an impurity in the synthesis or production process of Fluoxetine, a widely prescribed antidepressant medication.
Production Methods:
The production of METHYL-(3-PHENYL-PROPYL)-AMINE is not explicitly detailed in the provided materials. However, it is understood that this compound is a byproduct or impurity in the synthesis of Fluoxetine, which is manufactured through a series of chemical reactions.

Uses

Used in Pharmaceutical Quality Control:
METHYL-(3-PHENYL-PROPYL)-AMINE is used as a reference standard for the identification and quantification of impurities in Fluoxetine (F597100). The presence of this compound in Fluoxetine is monitored to ensure the quality, safety, and efficacy of the final drug product.
Used in Research and Development:
In the pharmaceutical industry, METHYL-(3-PHENYL-PROPYL)-AMINE serves as a research compound for the development of new drugs and the improvement of existing ones. Understanding the properties and effects of this compound can contribute to the advancement of pharmaceutical science and the creation of more effective treatments for various conditions.
Used in Regulatory Compliance:
METHYL-(3-PHENYL-PROPYL)-AMINE is used as a benchmark in the regulatory compliance process for the drug Fluoxetine. Regulatory agencies require the identification and control of impurities to ensure that the drug meets safety and efficacy standards before it can be approved for use in the general population.

Check Digit Verification of cas no

The CAS Registry Mumber 23580-89-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,5,8 and 0 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 23580-89:
(7*2)+(6*3)+(5*5)+(4*8)+(3*0)+(2*8)+(1*9)=114
114 % 10 = 4
So 23580-89-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H15N/c1-11-9-5-8-10-6-3-2-4-7-10/h2-4,6-7,11H,5,8-9H2,1H3

23580-89-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • USP

  • (1279826)  Fluoxetine Related Compound B  United States Pharmacopeia (USP) Reference Standard

  • 23580-89-4

  • 1279826-5ML

  • 14,578.20CNY

  • Detail

23580-89-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Methyl-N-(3-phenylpropyl)amine

1.2 Other means of identification

Product number -
Other names (3-phenylpropyl)methylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23580-89-4 SDS

23580-89-4Relevant articles and documents

Structure-Activity Relationship Studies of Pyrimidine-4-Carboxamides as Inhibitors of N-Acylphosphatidylethanolamine Phospholipase D

Mock, Elliot D.,Kotsogianni, Ioli,Driever, Wouter P. F.,Fonseca, Carmen S.,Vooijs, Jelle M.,Den Dulk, Hans,Van Boeckel, Constant A. A.,Van Der Stelt, Mario

, p. 481 - 515 (2021/02/05)

N-Acylphosphatidylethanolamine phospholipase D (NAPE-PLD) is regarded as the main enzyme responsible for the biosynthesis of N-acylethanolamines (NAEs), a family of bioactive lipid mediators. Previously, we reported N-(cyclopropylmethyl)-6-((S)-3-hydroxypyrrolidin-1-yl)-2-((S)-3-phenylpiperidin-1-yl)pyrimidine-4-carboxamide (1, LEI-401) as the first potent and selective NAPE-PLD inhibitor that decreased NAEs in the brains of freely moving mice and modulated emotional behavior [ Mock et al. Nat Chem. Biol., 2020, 16, 667-675 ]. Here, we describe the structure-activity relationship (SAR) of a library of pyrimidine-4-carboxamides as inhibitors of NAPE-PLD that led to the identification of LEI-401. A high-throughput screening hit was modified at three different substituents to optimize its potency and lipophilicity. Conformational restriction of an N-methylphenethylamine group by replacement with an (S)-3-phenylpiperidine increased the inhibitory potency 3-fold. Exchange of a morpholine substituent for an (S)-3-hydroxypyrrolidine reduced the lipophilicity and further increased activity by 10-fold, affording LEI-401 as a nanomolar potent inhibitor with drug-like properties. LEI-401 is a suitable pharmacological tool compound to investigate NAPE-PLD function in vitro and in vivo.

PRODUCTION OF AMINES VIA A HYDROAMINOMETHYLATION REACTION USING IMINIUM REACTANTS

-

Page/Page column 33-34, (2020/05/14)

Provided is a process for producing an amine via a hydroaminomethylation reaction of a non- aromatic C-C double bond, said process comprising a step of reacting a compound comprising a non-aromatic C-C double bond with an iminium ion in a solvent comprising an alcohol, wherein the iminium ion is represented by the following formula (I): wherein R1 and R2 are independently hydrogen or selected from the group consisting of an aliphatic hydrocarbon group which may be substituted, an aromatic hydrocarbon group which may be substituted, an aliphatic heterocyclic group which may be substituted, an aromatic heterocyclic group which may be substituted and of combinations thereof, such as an aralkyl group which may be substituted; and R1 and R2 may be bonded to each other to form a ring together with the nitrogen atom to which they are bound; and wherein R1 and R2 are not both hydrogen and at least one of R1 and R2 carries a hydrogen atom at a carbon atom in ex? position to the nitrogen atom of the iminium ion.

A General Acid-Mediated Hydroaminomethylation of Unactivated Alkenes and Alkynes

Kaiser, Daniel,Tona, Veronica,Gon?alves, Carlos R.,Shaaban, Saad,Oppedisano, Alberto,Maulide, Nuno

supporting information, p. 14639 - 14643 (2019/09/17)

In comparison to the extensively studied metal-catalyzed hydroamination reaction, hydroaminomethylation has received significantly less attention despite its considerable potential to streamline amine synthesis. State-of-the-art protocols for hydroaminomethylation of alkenes rely largely on transition-metal catalysis, enabling this transformation only under highly designed and controlled conditions. Here we report a broadly applicable, acid-mediated approach to the hydroaminomethylation of unactivated alkenes and alkynes. This methodology employs cheap, readily available, and bench-stable reactants and affords the desired amines with excellent functional group tolerance and impeccable regioselectivity. The broad scope of this transformation, as well as mechanistic investigations and in situ domino functionalization reactions are reported.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 23580-89-4